Mendelspod Podcast
By Theral Timpson
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Theral Timpson
Category: Natural Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 51
Reviews: 0
Episodes: 433
Description
Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.
www.mendelspod.com
www.mendelspod.com
| Episode | Date |
|---|---|
|
An Ethics First Approach to Genetic Research and Drug Development with Sarah LeBaron von Baeyer
|
May 02, 2024 |
|
How Do You Train Genomics AI? On Natural Selection Itself, Says VP of Illumina’s AI Lab, Kyle Farh
|
Apr 30, 2024 |
|
The Pre-Symptomatic Space with Patrick Short, Sano Genetics
|
Apr 25, 2024 |
|
Systemwide Implementation of Precision Medicine at UCHealth with David Kao
|
Apr 18, 2024 |
|
Is this New Tech a Game Changer for Spatial Biology?
|
Apr 11, 2024 |
|
Synthetic Biology in 2024 with John Cumbers
|
Mar 26, 2024 |
|
Illumina Scales Variant Calling and Genome Interpretation to Improve Gap in Genetic Testing with Sam Strom
|
Mar 21, 2024 |
|
The Renaissance in DNA Synthesis Continues: Cosimo Ducani, CEO, Moligo
|
Mar 19, 2024 |
|
Jennifer Wipf of Ginkgo Bioworks on RNA Therapeutics and Cell Therapy
|
Mar 12, 2024 |
|
Precision Medicine for Dogs: Christina Lopes, OneHealth
|
Feb 22, 2024 |
|
Taking Gene Therapy to the Next Level: Rahul Kakkar of Tome
|
Feb 15, 2024 |
|
Christian Henry of PacBio on Long Reads at Scale, Next Moves
|
Feb 13, 2024 |
|
Robert Michel, Editor at The Dark Report, on Gap in Genetic Testing
|
Feb 06, 2024 |
|
Turning to Next Gen Proteomics for Novel Biomarkers: Jon Brudvig and Bruce Wilcox
|
Jan 30, 2024 |
|
What Have We Learned from the Brain Map Project So Far? with Tom Nowakowski, UCSF
|
Jan 23, 2024 |
|
Quality Healthcare Should Not Depend on Which Book Club You Attend, Karen Tumulty of the Washington Post
|
Jan 16, 2024 |
|
Real Probiotics: Colleen Cutcliffe, CEO, Pendulum Therapeutics
|
Jan 09, 2024 |
|
Todd Druley of Mission Bio on Single Cell Multi-Omics
|
Jan 04, 2024 |
|
Kevin Davies on Gene Therapy in 2023
|
Dec 26, 2023 |
|
History and State of Proteomics 2023 with John Yates
|
Dec 19, 2023 |
|
New Philosophy of Biology Series on PBS: A Preview with Host Robert Lawrence Kuhn
|
Dec 12, 2023 |
|
Mapping the Meta Proteome: John Shon, CTO, Serimmune
|
Dec 05, 2023 |
|
Supercharged Killer Cells Effective Against Alzheimer’s: Paul Song, CEO, NKGen Biotech
|
Nov 28, 2023 |
|
Chris Hall and Rich Chen of Personalis on Next Gen MRD Testing
|
Nov 21, 2023 |
|
State of Sequencing 2023: Shawn Baker and Keith Robison
|
Nov 14, 2023 |
|
Newborn Sequencing 2023 Part II: What Evidence Is Enough?
|
Nov 07, 2023 |
|
Lincoln Nadauld on the State of Precision Medicine in 2023
|
Oct 17, 2023 |
|
Nothing Is "Undruggable:" Alex Federation, CEO, Talus Bio
|
Oct 12, 2023 |
|
Mass Spec Advances in a New Age of Proteomics: Rosy Lee, Thermo Fisher Scientific
|
Oct 10, 2023 |
|
This Is Very Cool: Treating Cancer with Sound
|
Oct 03, 2023 |
|
The Future of Clinical Proteomics with Jenny Van Eyk and Daniel Hornburg
|
Sep 27, 2023 |
|
Elinor Karlsson on Darwin’s Ark
|
Sep 18, 2023 |
|
Long DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech
|
Sep 13, 2023 |
|
Next Gen CRISPR Therapies with Trevor Martin, CEO of Mammoth Biosciences
|
Sep 05, 2023 |
|
13th Season Opener: Mike Snyder on Microsampling and Multi-Omic Profiling
|
Aug 24, 2023 |
|
Gene Patent Decision at 10 Years, State of Genetic Testing with Ellen Matloff, My Gene Counsel
|
Jun 15, 2023 |
|
Proteomics Bigger than Genomics, It’s Just Taking Time, Says Jeff Hawkins, CEO, Quantum-SI
|
Jun 01, 2023 |
|
Biden, AI, and DeSci: John Cumbers Previews SynBioBeta 2023
|
May 09, 2023 |
|
Proteomics Today Where Genomics Was in the 80s: Margaret Donovan and Asim Siddiqui of Seer on Landmark Study
|
May 08, 2023 |
|
Is This New Platform an Answer to the Reproducibility Crisis? with Guy Rohkin
|
Apr 27, 2023 |
|
Elegen Pioneers Long DNA Subindustry with CEO Matt Hill
|
Apr 19, 2023 |
|
Nevermind the $200 Genome, Element CEO Molly He Says Core Chemistry Capable of Much More
|
Mar 23, 2023 |
|
3D Genomics Solves Cancer Case Where Sequencing Came Up Short: Anthony Schmitt, Arima Genomics
|
Mar 16, 2023 |
|
New Spatial Company Maps Cell Surface Proteome without Imaging
|
Mar 08, 2023 |
|
John Greally on His Latest Review of Epigenomics
|
Feb 23, 2023 |
|
President of ASHG on Eugenics Apology, Diversity Initiative
|
Feb 15, 2023 |
|
23andMe Launches New Personalized Healthcare Initiative with Amy Sturm
|
Feb 02, 2023 |
|
Converting Digital to Biological: John Gill, Telesis Bio
|
Jan 23, 2023 |
|
50% Not Tested: Precision Oncology with Jerome Madison, Invitae
|
Jan 17, 2023 |
|
Paul Freemont on Synthetic Biology in the UK
|
Jan 05, 2023 |
|
The Bioengineered Hangover Cure: Changing the Conversation around GMOs with Zack Abbott of ZBiotics
|
Dec 22, 2022 |
|
Lance Baldo of Freenome on their Approach to Early Cancer Detection
|
Dec 08, 2022 |
|
Mara Aspinall on COVID
|
Nov 29, 2022 |
|
Terry Lo of Vizgen on Spatial Genomics
|
Nov 27, 2022 |
|
Proteomics at Scale Empowers Genomics in New Ways: Dale Yuzuki, Olink
|
Nov 22, 2022 |
|
A New Tool in the Genomics Kit with Ivan Liachko of Phase Genomics
|
Nov 14, 2022 |
|
Paul Kruszka of GeneDx/Sema4 on Groundbreaking Newborn Sequencing Study
|
Nov 13, 2022 |
|
Is PGx Having a Moment? Kristine Ashcraft, Invitae
|
Nov 10, 2022 |
|
Christian Henry on Revio, Onso and the New Vision at PacBio
|
Nov 03, 2022 |
|
The Revolution in Single Molecule Sequencing Continues: Vijay Ramani, UCSF
|
Oct 18, 2022 |
|
Will Hwang of Mass General on Discovery of Novel Pancreatic Cancer Cell Subtype
|
Oct 11, 2022 |
|
Going Beyond Time Barriers: Arutha Kulasinghe on the Power of New Spatial Biology Tools
|
Oct 07, 2022 |
|
Invitae’s Data Manager, Farid Vij, on New Genome Management Platform
|
Sep 22, 2022 |
|
Satellite Bio out with a New Tissue Based Approach to Regenerative Medicine
|
Aug 25, 2022 |
|
We Have to Get Sequencing Back to Moore’s Law: Gilad Almogy, Ultima Genomics
|
Jun 23, 2022 |
|
RNA Therapeutics: A New Paradigm for Drug Development? Tim Mercer, BASE Lab, U of Queensland
|
Jun 16, 2022 |
|
The System is Working. We Need More Engagement, Says ClinVar Champion Heidi Rehm of Mass General in Her Update on the State of Genomic Medicine in 2022
|
Jun 09, 2022 |
|
The Promise of Exosomes Now Realized, Says Paul Billings, CEO, Biological Dynamics
|
Jun 02, 2022 |
|
Lee Cronin on Origin of Life, Genomics, Aliens and More
|
Jun 01, 2022 |
|
Eric Green on the Future of the NHGRI
|
May 28, 2022 |
|
5-Base Sequencing: Jonas Korlach and Tomi Pastinen
|
May 25, 2022 |
|
More Cancer Patients Die from Infections than Cancer, Says Alec Ford, CEO of Karius
|
May 18, 2022 |
|
Some of the Lowest Hanging Fruits in Precision Medicine: Michelle Whirl-Carrillo on Pharmacogenomics
|
May 10, 2022 |
|
John Nelson of GE Research Talks Vaccines on Demand, Enzymatic Synthesis, and the Era of Writing DNA
|
Apr 14, 2022 |
|
A New Generation Comfortable Doing a Thousand Things at a Time Is Reinventing Life Science Says Joe Beechem of NanoString
|
Apr 07, 2022 |
|
Enabling a New Age of Unbiased Proteomics Discovery: Omid Farokhzad, Seer Inc.
|
Mar 31, 2022 |
|
The Rise of MRD Testing and the Field of Fragmentomics with Sugganth Daniel, Invitae
|
Mar 17, 2022 |
|
The Invention of Enzymatic DNA Synthesis with Sylvain Gariel, DNA Script
|
Mar 03, 2022 |
|
Akoya Biosciences Launches New Integrated Spatial Platform: Our First Interview with CEO Brian McKelligon
|
Feb 24, 2022 |
|
Harlan Robins on How T-cell Focused COVID Vaccines Can Move Us Toward Endemicity
|
Feb 16, 2022 |
|
Twist Bioscience: A New Kind of DNA Synthesis Company
|
Feb 10, 2022 |
|
Going High Resolution with 10X Genomics: Michael Schnall-Levin
|
Jan 27, 2022 |
|
George Church and Ben Lamm on the Launch of Colossal Biosciences
|
Jan 20, 2022 |
|
We Might Be the Comeback Kids of the Universe: Chris Mason on His Plan for the Next 500 Years
|
Dec 21, 2021 |
|
Invitae and PacBio CEOs Share Details of Clinical Sequencing Partnership
|
Dec 07, 2021 |
|
Building on the Knowledge Base of Developer Community, LuminexPLORE Lab Offers Custom Insights: Jackie Surls, Director
|
Nov 30, 2021 |
|
DNA Script Takes DNA Synthesis Back to the Bench with Enzymatic Tech: Thomas Ybert, CEO
|
Nov 17, 2021 |
|
Tumor Evolution in Context with Christina Curtis
|
Nov 11, 2021 |
|
The History of mRNA Vaccines with Elie Dolgin
|
Nov 04, 2021 |
|
Hundreds of Thousands of Biological Molecules Undiscovered in Plant Chemical Space Says Founder of New Drug Discovery Company
|
Nov 02, 2021 |
|
Quantitative Pathology with David Rimm, Yale
|
Oct 25, 2021 |
|
The State of Comprehensive Genomic Profiling at One of America’s Largest Health Systems with Carlo Bifulco
|
Oct 19, 2021 |
|
Inside the World of Genome Engineering at Amyris with Kirsten Benjamin, VP of R&D
|
Oct 04, 2021 |
|
Clinical Genetics 2021 Highlights: Laura Hercher, Host of the Beagle Landed Podcast
|
Sep 21, 2021 |
|
A New Way to Phenotype Life: Chris Mason Talks Spatial Biology, His New Book
|
Aug 10, 2021 |
|
The Impact of Spatial Technology on Childhood Cancers with David Steffin, Texas Children's
|
Aug 03, 2021 |
|
Robert Green: Newborn Sequencing Is the Goal Here in the U.S.
|
Jul 29, 2021 |
|
The Studies Are In—Optical Mapping Can Replace Traditional Cytogenetics Tests
|
Jul 12, 2021 |
|
Amy Sturm of Geisinger on FH Testing and New Implementation Science
|
Jul 07, 2021 |
|
Out of the Reductionist Trap: Brad Gray of NanoString on Spatial Biology
|
May 19, 2021 |
|
Precision Oncology at the Community Level with Lee Schwartzberg
|
May 06, 2021 |
|
Daniel Kraft on the Digitome and COVID
|
Apr 19, 2021 |
|
Orchid Health Is 1st in the World to Offer Whole Genome Couple's Report
|
Apr 07, 2021 |
|
PacBio and Labcorp Team Up on a Global Pan-Pathogen Surveillance Network
|
Apr 01, 2021 |
|
Will High Sensitivity Proteomics Enable a New Paradigm in Precision Health? with Kevin Hrusovsky, Quanterix
|
Mar 23, 2021 |
|
A Liquid Biopsy Technology that Doesn't Degrade the Sample: Raj Krishnan of Biological Dynamics
|
Mar 11, 2021 |
|
The Future of Big Biology: Bionano at AGBT
|
Mar 04, 2021 |
|
Playing Catch Up--Viral Surveillance in the U.S. with Will Lee of Helix
|
Feb 16, 2021 |
|
The Coronavirus, A Year On with Carl Zimmer
|
Jan 28, 2021 |
|
Spatial Biology Enables The Cancer Immunome Project
|
Jan 21, 2021 |
|
The CRISPR Saga with Kevin Davies
|
Dec 22, 2020 |
|
PacBio’s Never Been Stronger: New CEO, Christian Henry, Shares His Vision
|
Dec 15, 2020 |
|
Keith Robison on the State of Sequencing: 2020 Edition
|
Nov 17, 2020 |
|
Halloween with Nathan and Laura: The Spooky and Creepy of Genomics
|
Oct 30, 2020 |
|
When and Why Whole Genome Sequencing Should Be Standard of Care: Stephen Kingsmore of Rady Children’s
|
Oct 27, 2020 |
|
Limited Genetic Diversity Affects Us All
|
Oct 22, 2020 |
|
Genomics England Making Significant Strides in System Built on Trust in NHS
|
Oct 08, 2020 |
|
September 2020 Review with Nathan and Laura: Vaccine Choice, Dwarfism, Research Volunteerism
|
Oct 02, 2020 |
|
Bob Nussbaum on the State of Genetic Testing: 2020 Edition
|
Sep 22, 2020 |
|
SynBioBeta 2020 with John Cumbers
|
Sep 15, 2020 |
|
Mapping Intracellular Context: Garry Nolan on Spatial Biology
|
Sep 09, 2020 |
|
August 2020 Review: Radical Shift on LDT Policy, First Pan-Cancer Liquid Biopsies, and New Alzheimer’s Test
|
Sep 01, 2020 |
|
Using CRISPR Genome Editing Tools, Willow Biosciences out with First Synthetic Cannabinoid
|
Aug 26, 2020 |
|
The Pros and Cons of Expanded Carrier Screening with Mary Norton, UCSF
|
Jun 16, 2020 |
|
Is This A Unique Time for Science? We Ask Sci-fi Writer Kim Stanley Robinson
|
Jun 13, 2020 |
|
May 2020 with Nathan and Laura: Vaccine News, Notre Dame Argument, COVID Genetic Targets
|
Jun 01, 2020 |
|
Matt Loose on "Read Until" or Adaptive Sequencing
|
May 28, 2020 |
|
The Current State of Coronavirus Vaccines with Jeff Stein, Cidara Therapeutics
|
May 21, 2020 |
|
April 2020 Review with Nathan and Laura: Ioannidis Scandal, Antibody Testing, Ethics Questions
|
May 01, 2020 |
|
Lab Director Speaks to the Challenges of COVID-19 Testing: Elaine Lyon, HudsonAlpha
|
Apr 14, 2020 |
|
FDA in the Time of Coronavirus: Understanding the New VALID Act with Turna Ray, GenomeWeb
|
Apr 07, 2020 |
|
March 2020 Review with Nathan & Laura: Corona Gets Personal, Where Are the Tests?, the VALID Act, Some non-Corona Science
|
Apr 02, 2020 |
|
90% Go Undiagnosed, Says Geisinger’s Amy Sturm of FH Patients
|
Mar 26, 2020 |
|
Lisa Alderson on Her Telegenetics Firm, Genome Medical, Also Speaks to the DTC Downturn
|
Mar 10, 2020 |
|
February 2020 Review with Nathan and Laura: Coronavirus, Medicare for All, and Live from AGBT
|
Feb 28, 2020 |
|
Pouria Sanae on the DTC Slowdown and His New Precision Health Testing Platform
|
Feb 13, 2020 |
|
January 2020 Review: Genetic Counselors vs ACMG, 23andMe Layoffs, Privacy
|
Jan 31, 2020 |
|
End-of-Decade Review, What's Next? with Nathan and Laura
|
Dec 27, 2019 |
|
Ewan Birney on Race, UK Genomics
|
Dec 17, 2019 |
|
November 2019 with Nathan and Laura: Happy Birthday CRISPR Babies, 23andMe for Embryo Selection, and Golden Rice, Almost
|
Dec 02, 2019 |
|
Learning from the Field's Mistakes, Ancestry.com Rolls out Physician Ordered Health Testing
|
Nov 26, 2019 |
|
The Gene Edited Babies Saga - A Year Later with Hank Greely
|
Nov 22, 2019 |
|
Improving Quantitative Evidence for Genetic Tests: Carlos Araya, Invitae
|
Nov 14, 2019 |
|
The Meteoric Rise of Twist Bioscience and the Wild Demand for DNA: Emily Leproust, CEO
|
Nov 07, 2019 |
|
October 2019 Review with Nathan and Laura: Prime Editing, Vertex Win, and ASHG
|
Nov 01, 2019 |
|
Should We Increase Panel Testing for All Breast Cancer Patients?
|
Oct 24, 2019 |
|
Genomics Going from a Passive to an Active Science: John Stuelpnagel on the “Write” Revolution
|
Oct 22, 2019 |
|
Why Isn’t Personalized Medicine Being Mentioned by the Presidential Contenders? Ed Abrahams on Drug Pricing, Genetic Testing, and the State of the Industry in 2019
|
Oct 15, 2019 |
|
Karen Miga on the Next Era of Genomics
|
Oct 07, 2019 |
|
September 2019 Review with Nathan and Laura: Same-Sex Genetics, Mosquitos, and Another DTC Scandal
|
Oct 01, 2019 |
|
We Can See Tumor Heterogeneity. Now What? We Ask Cathy Smith, UCSF
|
Sep 17, 2019 |
|
Hallelujah! A Universal Flu Preventative and Therapy with Jeff Stein, Cidara
|
Sep 12, 2019 |
|
'The Movement:' John Cumbers Previews the Rapidly Growing SynBioBeta 2019
|
Sep 03, 2019 |
|
Anya Prince on Our Current Vulnerability to Genetic Discrimination
|
Aug 13, 2019 |
|
Do Long Reads Hold Answers for Alzheimer’s? with Mark Ebbert, Mayo
|
Aug 01, 2019 |
|
With Nanopore Sensing Beyond Sequencing, Ontera Takes 'Lab' to the Field
|
Jul 25, 2019 |
|
Mark Chaisson on Two New Structural Variation Papers
|
Jul 17, 2019 |
|
Early Cancer Detection: Is This Company Ahead of Grail?
|
Jul 09, 2019 |
|
June 2019 Review with Nathan and Laura: Gene Patents, Grail, Dr. Lynch
|
Jul 01, 2019 |
|
Should Genomic Screening Be Standard of Care? with Adam Buchanan, Geisinger
|
Jun 25, 2019 |
|
May 2019 Review with Nathan and Laura: Gene Therapies, DTC Shifts, Gender and Sports
|
May 31, 2019 |
|
Toward the Human Pan Genome with Adam Phillippy, NHGRI
|
May 23, 2019 |
|
Laura Hercher on the DTC Genetic Testing Landscape
|
May 16, 2019 |
|
Arcadia Biosciences Pivots to Bring Us Non-GMO, High Fiber GoodWheat and Better Cannabis
|
May 09, 2019 |
|
April 2019 Review with Nathan and Laura: uBiome Raided by FBI, PRS for Obesity, and a Gene Therapy Cure
|
May 02, 2019 |
|
The Era of the Social Genome with Rodrigo Martinez, Veritas Genetics
|
Apr 18, 2019 |
|
Reassessing Alzheimer’s with Larry Goldstein, UCSD
|
Apr 09, 2019 |
|
Family Surprises Care of the Home DNA Test with Brianne Kirkpatrick
|
Apr 04, 2019 |
|
March 2019 with Nathan and Laura: Old Envelopes, Wooly Mammoth DNA, and the Night King
|
Mar 29, 2019 |
|
Single Cell Analysis Shows Important New Detail in Key Clinical Study of AML: Koichi Takahashi, MD Anderson
|
Mar 21, 2019 |
|
Science Communication in a Post Fact World with Erik Clausen
|
Mar 06, 2019 |
|
February 2019 Review with Nathan and Laura: Family Surprises, IQ Profiling, and Chinese Surveillance
|
Mar 01, 2019 |
|
Heretic No Longer? Meet Michael Joyner, Precision Medicine’s Critic-in-Chief
|
Feb 26, 2019 |
|
The Internet of Biology Revolution-For Real This Time, with Brett Goldsmith, Cardea
|
Feb 06, 2019 |
|
January 2019 Review with Nathan and Laura: Cloning, CRISPRing, DTC, and Paleogenomic Overreach
|
Feb 01, 2019 |
|
Cara O'Neill of the Cure Sanfilippo Foundation Tells Her Story
|
Jan 28, 2019 |
|
PregSource: The NIH’s Crowdsourcing Project for Pregnancy Data with Caroline Signore
|
Jan 24, 2019 |
|
Meet Christian, Janos, and the New World of 3D Oncology
|
Jan 17, 2019 |
|
Has Computational Modeling for Cancer Genomics "Arrived?" with Shirley Liu, Dana Farber
|
Jan 08, 2019 |
|
Amy Harmon of the NYT on Race & Genetics, Women in Science
|
Dec 27, 2018 |
|
CRISPR or Not, You Can't Genetically Enhance Humans, Says Sci-Fi Author Kim Stanley Robinson
|
Dec 20, 2018 |
|
The New World of Infectious Disease Diagnosis: Out in the Field with David Hong of Karius
|
Dec 13, 2018 |
|
California Life Science Industry Steps to New Heights - the 2019 Edition with Sara Radcliffe
|
Dec 04, 2018 |
|
Nathan and Laura on CRISPRed Babies and Other November 2018 Stories
|
Nov 29, 2018 |
|
Ellen Matloff on a New Digital Genetic Counseling Product for DTC Customers
|
Nov 15, 2018 |
|
Connecting the Dots for a Community of Rare Disease Patients: Terri Klein, MPS Society
|
Nov 08, 2018 |
|
Keith Robison and Shawn Baker on Illumina Buyout of PacBio
|
Nov 02, 2018 |
|
October 2018 Review with Nathan and Laura: ASHG Does Race, Parents Do Gene Therapy, Unsung Demons
|
Nov 01, 2018 |
|
A Point-of-Care CBC Test Based on a Few Drops of Blood—Is This the Real Thing? with Danny Levner, Sight Diagnostics
|
Oct 25, 2018 |
|
It’s a Gold Rush in Single Cell Genomics, Says Joachim Schultze, U of Bonn
|
Oct 15, 2018 |
|
A Market Solution for Biospecimen Quality Standards with Matt McLoughlin, Scientist.com
|
Oct 02, 2018 |
|
September 2018 with Nathan and Laura: Studying the Same Genes and the Matt Fender Story
|
Sep 28, 2018 |
|
Single Cell Sequencing Tailor Made for Nephrology, Says Vivek Bhalla, Stanford
|
Sep 20, 2018 |
|
It’s the Social Factors, Stupid! Lisa Suennen on Healthcare, Her Career, Digital Health Investing, and . . . Just Being Herself
|
Sep 13, 2018 |
|
Concerned About DTC Test Quality? Ask Two Questions, Says Daryl Pritchard, PMC
|
Sep 05, 2018 |
|
August 2018 Review with Nathan and Laura: The polygenic month
|
Aug 31, 2018 |
|
An International Perspective on How to Improve Biobanking with Kirstin Goldring
|
Aug 21, 2018 |
|
A Seqster Preview with Founder Ardy Arianpour
|
Aug 16, 2018 |
|
Detective Stories from the Genomic War Room with Ramesh Hariharan
|
Jul 26, 2018 |
|
Should Biobanking Come Under CLIA? Shannon McCall, Duke
|
Jul 17, 2018 |
|
Pharma Stepping Up, Footing the Bill for Genetic Testing & Counseling: Jordanna Mora, Alnylam
|
Jun 12, 2018 |
|
Are We Asking Too Much of Genomics in Cancer Research? Tony Letai, Dana Farber
|
Jun 07, 2018 |
|
I Won’t Rest Until We Have Quality Standards in Place for Biospecimens: Carolyn Compton, ASU
|
Jun 05, 2018 |
|
May 2018 with Nathan and Laura: The Free Exome, California Database, and Mosaicism
|
Jun 01, 2018 |
|
Has Diagnostic Testing Plateaued? Alka Chaubey, Greenwood Genetic Center
|
May 24, 2018 |
|
A New Way for DTC? Nathan Pearson, Root Deep Insight
|
May 17, 2018 |
|
Genetic Testing in the Age of Trump: Hank Greely, Stanford
|
May 10, 2018 |
|
Genetic Testing is Dead, Long Live Genetic Testing: Sean George of Invitae
|
May 03, 2018 |
|
April 2018 with Nathan and Laura: Golden State Killer and the Cancer Prediction Space
|
May 01, 2018 |
|
Liquid Biopsy for Infectious Disease with Mickey Kertesz, Karius
|
Apr 24, 2018 |
|
Nanopore Sequencing and the Future of Cancer Research with Chia-Lin Wei, JAX
|
Apr 18, 2018 |
|
A New Method for Long Reads: Hanlee Ji of Stanford on Cancer Genomics Tech 2018
|
Apr 10, 2018 |
|
March 2018 in Genomics with Nathan & Laura: DTC BRCA and Revisiting All of Us
|
Apr 01, 2018 |
|
With More Tools in the Box, Lon Cardon Says We’re in a New Age of Drug Development
|
Mar 21, 2018 |
|
Personalized Medicine in the Trump Era with Edward Abrahams
|
Mar 15, 2018 |
|
Eric Schadt and Sema4 Try the Consumer Model with Newborn Screening Panel
|
Mar 06, 2018 |
|
February 2018 in Genomics with Nathan & Laura: 23andMe Goes for the Gold, Trump Year One
|
Mar 01, 2018 |
|
State of Sequencing 2018 with Keith Robison, Omics! Omics! Blogger
|
Feb 20, 2018 |
|
Direct RNA-Seq Project Shows Nanopore Sequencing Can Reveal New Insights into Basic Biology: Winston Timp, JHU
|
Feb 06, 2018 |
|
January 2018 Review Show with Nathan and Laura: CRISPR vs The Immune System, Biotech Math, and MinION's Big Test
|
Feb 01, 2018 |
|
Going Beyond the Liver with RNAi: Chris Anzalone of Arrowhead Pharma
|
Jan 23, 2018 |
|
Vice Chancellor Keith Yamamoto on UCSF’s Role in Medicine Today
|
Jan 15, 2018 |
|
The Global Business of Reproductive Genetic Testing with Gary Harton, Igenomix
|
Jan 11, 2018 |
|
The State of Genomics 2018 with Nathan, Laura, and Misha
|
Jan 08, 2018 |
|
Sharon Begley of STAT News
|
Dec 19, 2017 |
|
A New “Middle Way” for Genomics, with Physical Chemist, Yuval Ebenstein
|
Dec 13, 2017 |
|
Sara Demy on Biotech CEOs
|
Dec 04, 2017 |
|
November 2017 with Nathan and Laura: The Stem Cell Story We’ve All Been Waiting For and a Sea Change for DTC Testing
|
Dec 01, 2017 |
|
Seattle Startup Takes Precision Oncology to the Next Step: Carla Grandori, CEO, SEngine
|
Nov 16, 2017 |
|
Immuno Oncology 2017: Looking Back, Looking Forward with Rachel Laing and Olivier Lesueur
|
Nov 14, 2017 |
|
Huh? 30 Million Americans Have a Rare Disease? Howard Jacob on the State of Clinical Sequencing
|
Nov 09, 2017 |
|
With their Own Manufacturing Facility, Seattle Children’s Goes Big into CAR-T, Rare Disease
|
Nov 07, 2017 |
|
With Immuno Oncology Comes a New Focus on Rare Cells
|
Nov 01, 2017 |
|
We've Become Too Single Variant Centric, Says Deanna Church on Genome Analysis
|
Oct 12, 2017 |
|
Clinicians Show High Demand for Single Cell Sequencing, Says Bobby Sebra of Mt. Sinai
|
Oct 05, 2017 |
|
September 2017 with Nathan and Laura: Venter Blunder, RNAi Returns, and Monthly Science Moments
|
Oct 02, 2017 |
|
Charting the Dark Matter of Cancer Genomes with Jim Broach
|
Sep 26, 2017 |
|
Why Childhood Cancers Need Their Own Gene Panel: Tim Triche
|
Sep 21, 2017 |
|
Exploring the Exome and the Future of Genomics with Jay Shendure
|
Sep 13, 2017 |
|
August 2017 Review with Nathan and Laura: CAR-T Cashes In, Embryos Edited in US, and the Invitae Incident
|
Sep 01, 2017 |
|
The First In-Human Gene Editing Trial in the U.S. - And It’s Not with CRISPR
|
Aug 08, 2017 |
|
Thermo, Pfizer, and Novartis Pull Off a First for NGS in Lung Cancer
|
Aug 03, 2017 |
|
Making Genetic Testing Mainstream Medicine with Sean George, Invitae
|
Aug 01, 2017 |
|
Need Better Standards for Your Clinical Assays? NIST Can Help
|
Jul 27, 2017 |
|
Turning on Your DNA with Justin Kao, Helix
|
Jul 25, 2017 |
|
Will This New Nano Technology Be the Microarray of Genomic Structural Variation? Barrett Bready, Nabsys
|
Jul 20, 2017 |
|
George Church on What Comes After CRISPR
|
Jul 13, 2017 |
|
Is CRISPR Controversy Science or Spin? June 2017 Review with Nathan and Laura
|
Jun 30, 2017 |
|
We Need a Google Maps for Metagenomics, Says Rob Knight, UCSD
|
Jun 27, 2017 |
|
Move Over PDL1: New Test Combo Adds RNAseq to Better Track Immune Escape
|
Jun 22, 2017 |
|
The Last Major Disease To Be Studied? Ron Davis of Stanford Thinks So
|
Jun 15, 2017 |
|
On Bioinformatics Data Sharing and Collaboration: Andrew Carroll, DNAnexus
|
Jun 08, 2017 |
|
Grail Merger, Genomic Autopsies, Overtreatment Alarm, and Controversy at Ancestry.com: May 2017 Review with Nathan and Laura
|
Jun 01, 2017 |
|
Is Population Medicine Failing Us? Michel Accad
|
May 25, 2017 |
|
Deep Omics Profiler, Mike Snyder, Now Turns to Wearables
|
May 18, 2017 |
|
Over $1 Billion Invested this Past Year: Synthetic Biology in 2017 with John Cumbers
|
May 11, 2017 |
|
Green Light for DTC, Blood Mammograms, and Ancient DNA: April 2017 with Nathan and Laura
|
May 01, 2017 |
|
With 50 Million Users, Is Academia.edu Speeding Up Science?
|
Apr 18, 2017 |
|
How to Improve Lab Tests in the Absence of FDA Regulation?
|
Apr 13, 2017 |
|
Known for Medical Devices, 116 Yr Old BD Makes a Bold Move in Genomics
|
Apr 05, 2017 |
|
Proposed NIH Cuts, Undermining GINA, and Game Changing Drugs: March 2017 with Nathan and Laura
|
Mar 31, 2017 |
|
Art in the Lab (Falling in Love with Bacteria)
|
Mar 28, 2017 |
|
Flint Whistleblower Says Today's Science Is to Blame for Its Own Lack of Public Trust
|
Mar 16, 2017 |
|
The Story of Geisinger and Doing Genomic Medicine at the Right Pace
|
Mar 08, 2017 |
|
In-Situ Sequencing, CRISPR Patents, and Racist Milk Drinkers: February 2017 with Nathan and Laura
|
Mar 01, 2017 |
|
New Pocket Size Nanopore Device Could Revolutionize Diagnostic and Other Testing
|
Feb 20, 2017 |
|
By Changing a Basic Lab Step, Acoustic Liquid Transfer Having a Broad Impact
|
Feb 13, 2017 |
|
Many Biologists Today Don’t Have Enough Computer Science to Use the Databases
|
Feb 09, 2017 |
|
Cardiologists Love Genomics: Euan Ashley, Stanford
|
Feb 07, 2017 |
|
Scientists vs Trump: January 2017 with Nathan and Laura
|
Feb 02, 2017 |
|
Want to Stop Smoking? Start with Epigenetic Biomarker that Tells Doc the Truth
|
Jan 31, 2017 |
|
When an Exome Test Is Part of the Therapy and Not a Diagnostic: John West on Personalis and Personalized Cancer Vaccines
|
Jan 24, 2017 |
|
People Told Us It Was Impossible: UCSC’s Mark Akeson on Nanopore Sequencing
|
Jan 18, 2017 |
|
When Long Reads are Double the Price of Short Reads, Short Reads Are Dead, Says Evan Eichler
|
Jan 12, 2017 |
|
Genomics in 2016: Nathan and Laura Name Their Top Stories
|
Dec 28, 2016 |
|
Hank Greely on “The End of Sex" and Other Stuff
|
Dec 22, 2016 |
|
How to Scale Cancer Genomics, with Marco Marra, UBC
|
Dec 06, 2016 |
|
What Does the Election Mean for Genomics? November 2016 with Nathan and Laura
|
Dec 01, 2016 |
|
The Saga Continues: Ethan Perlstein, Indie Scientist, Part 3
|
Nov 29, 2016 |
|
Biomarker Panel to Predict Type 1 Diabetes
|
Nov 17, 2016 |
|
Can You Name the World’s Largest Single Disease Research Charity?
|
Nov 15, 2016 |
|
Why Diversity Is the Only Path Forward: Sarah Tishkoff on African Genomics
|
Nov 03, 2016 |
|
October 2016 with Nathan and Laura
|
Nov 01, 2016 |
|
We’re Over Halfway There: Baylor's Richard Gibbs on Clinical Genetics
|
Oct 25, 2016 |
|
With FDA Guidance on LDTs Still Not Out, What Are Labs Doing?
|
Oct 19, 2016 |
|
Reference Genome Making Major Strides in Ethnic Diversity, Says Valerie Schneider, NCBI
|
Oct 11, 2016 |
|
September 2016 with Nathan and Laura
|
Oct 04, 2016 |
|
Luke Timmerman on His New Biography of Lee Hood
|
Sep 27, 2016 |
|
How Personalized is Personalized Medicine? Krister Wennerberg on FIMM’s Individualized Systems Medicine
|
Sep 22, 2016 |
|
Digital PCR Opens Up New Liquid Biopsy Opportunity in Melanoma Treatment: David Polsky, NYU
|
Sep 20, 2016 |
|
Erica Ramos on Her Pioneering Role as Genetic Counselor for Industry
|
Sep 14, 2016 |
|
August 2016 with Nathan and Laura
|
Sep 01, 2016 |
|
A Maniacal Commitment to Science: Peering into Regeneron’s Genetics Center with Jeff Reid
|
Aug 18, 2016 |
|
The Days of Miracle and Wonder: Laura Hercher on Genetic Counseling, Part 2
|
Jul 30, 2016 |
|
The Days of Miracle and Wonder: Laura Hercher on Genetic Counseling, Part 1
|
Jul 30, 2016 |
|
A Precision Medicine Platform Comes of Age: Jonathan Hirsch, Syapse
|
Jul 21, 2016 |
|
FDA’s Liz Mansfield on New NGS Guidances
|
Jul 19, 2016 |
|
How Is the Brexit Impacting Genomics? with Clare Turnbull and Hadyn Parry
|
Jul 12, 2016 |
|
It’s Not Really Bulls and Bears: John Carroll on His New Gig, the Brexit, and a New Metaphor for the Market
|
Jul 07, 2016 |
|
June 2016 with Nathan and Laura: GMO Labeling, Misspelling CRISPR, Sequenom Patent Loss, SmidgIon
|
Jul 05, 2016 |
|
Know Then Thyself: Kari Stefansson, deCODE genetics
|
Jun 30, 2016 |
|
Sequenom Patent Loss a Threat to Personalized Medicine, Says Kevin Noonan
|
Jun 29, 2016 |
|
Bringing Home Some Diagnostics Gold: Brad Gray, NanoString Show How It’s Done
|
Jun 24, 2016 |
|
Mukherjee Mess-up, the Secret Harvard Meeting, and Success in Gene Therapy: May 2016 with Nathan and Laura
|
Jun 06, 2016 |
|
When Do We Move to Population Based Cancer Screening for Those with High Genetic Risk? Josh Schiffman, U of U
|
May 24, 2016 |
|
The Solid Future of Liquid Biopsies with Michael Nall, Biocept
|
May 19, 2016 |
|
Genomics Is Oversubscribed, Says Creator of BLAST
|
May 12, 2016 |
|
With 10K Genomes Sequenced, Genomics England in High Gear: Clare Turnbull, Clinical Lead
|
May 05, 2016 |
|
April 2016 with Nathan and Laura: Big Money, More CRISPR Studies, Genomic Superheroes, and a Pot Chaser
|
May 02, 2016 |
|
A Sneak Peek into the Future of Clinical Genomics with Ben Solomon, Inova
|
Apr 28, 2016 |
|
Preprints and the Future of Science Publishing with Jason Hoyt, PeerJ
|
Apr 11, 2016 |
|
Flipping Drug Development Upside Down: Niven Narain, BERG Health
|
Apr 06, 2016 |
|
March 2016 with Nathan and Laura: Genomic Jenga and the Creator, the Anti-Abortion Lobby and Genetic Testing, and Theranos, Again
|
Apr 01, 2016 |
|
Medicine and the Limits of Science with Michel Accad, MD
|
Mar 30, 2016 |
|
How Good are Linked Reads? Serge Saxonov, 10X Genomics
|
Mar 15, 2016 |
|
A Home Run on the First Hit: PacBio’s Jonas Korlach
|
Mar 08, 2016 |
|
Digital Pathology at Scale: Epic Sciences Takes CTC Technology to the Next Level
|
Mar 03, 2016 |
|
February 2016: Mosquitos, Preprints, and that Rocking White House Summit
|
Mar 01, 2016 |
|
BioNano Genomics Stakes Out Sequencing Territory as They Discover Lots of De Novo Variants in Reference Genome Projects
|
Feb 25, 2016 |
|
Is Oxitec Ready to Scale as Governments Seek Options to Control the Zika Virus?
|
Feb 23, 2016 |
|
Human Genome Turns 15: Mike Hunkapiller
|
Feb 04, 2016 |
|
January 2016: Landergate, Grail, and Cancer Moonshot
|
Feb 01, 2016 |
|
Frontiers of Sequencing: Putting Long Reads and Graph Assemblies to Work
|
Jan 28, 2016 |
|
Why Drugs Are Priced So High and Diagnostics So Low
|
Jan 21, 2016 |
|
Who Is John Ioannidis?
|
Jan 14, 2016 |
|
Cancer: Year in Review 2015 with Anna Barker
|
Dec 30, 2015 |
|
Sci-Fi Author Kim Stanley Robinson Talks Life Science 2015
|
Dec 22, 2015 |
|
Yes to FDA Regulation of LDTs, But We Need a New Framework, Says David Spetzler
|
Dec 03, 2015 |
|
Genomics and the Cloud Going Through “a Second Puberty,” says AWS’ Angel Pizarro
|
Nov 24, 2015 |
|
Hot Biotech Market Neglects Stem Cell Therapies, Says CIRM's Neil Littman
|
Nov 18, 2015 |
|
The Future of Diagnostics Reimbursement with Bruce Quinn
|
Nov 12, 2015 |
|
Framingham for the Modern Era: Josie Briggs on the Precision Medicine Initiative
|
Nov 04, 2015 |
|
Do Alternate Proposals to Regulate LDTs Stand a Chance?
|
Oct 29, 2015 |
|
Does the Reproducibility Project in Cancer Biology Offer a Model for a New Kind of Science Auditing?
|
Oct 27, 2015 |
|
After CMS Announcement, Peter Maag and CareDx Fight for Life
|
Oct 22, 2015 |
|
The Goal Is De Novo Assembly in the Clinic, Says Jim Lupski, Baylor
|
Oct 20, 2015 |
|
Cliff Reid Says New Supersequencer Leads the Pack for High Throughput Clinical Sequencing
|
Oct 16, 2015 |
|
Defending the Value of Biotech Innovation in California: Sara Radcliffe, CLSA
|
Oct 09, 2015 |
|
Long Read Sequencing Dramatically Improves Blood Matching: Steven Marsh, Anthony Nolan Institute
|
Oct 06, 2015 |
|
The World of DIY Genomics with K T Pickard
|
Oct 01, 2015 |
|
Sequencing in Space: Chris Mason, Cornell
|
Sep 24, 2015 |
|
Is the Future of Biology a Return to Chemistry? Carolyn Bertozzi, Stanford
|
Sep 22, 2015 |
|
Going Beyond the $1,000 Genome with Mark Gerstein
|
Sep 17, 2015 |
|
Creating the Foundation of Genomics: Marc Salit, NIST
|
Sep 10, 2015 |
|
Still Unhappy with FDA’s Plan to Regulate LDTs, Professional Lab Groups Go Direct to the Senate
|
Sep 08, 2015 |
|
A Diagnostic Success Story with Alka Chaubey, Greenwood Genetic Center
|
Sep 03, 2015 |
|
With Two New Easy-to-Use Sequencing Instruments, Thermo Readies for Primetime in the Clinic
|
Sep 01, 2015 |
|
Here's Looking at Euclid
|
Aug 28, 2015 |
|
Is This the Future of Clinical Trials for Cancer? Stanley Hamilton on the NCI’s New MATCH Trial
|
Aug 27, 2015 |
|
Brian Kennedy and Aubrey de Grey on their Converging Approaches to Aging Research
|
Aug 25, 2015 |
|
The Business of Aging and Three Reasons Why the FDA Drug Approval Rate Is So High
|
Aug 21, 2015 |
|
New York Genome Center’s Nathan Pearson on Public Outreach for Genomics
|
Aug 19, 2015 |
|
Tim Triche on Using Arrays for Cancer Research
|
Jul 31, 2015 |
|
Thermo’s Chris Linthwaite on Sequencing the Ebola Virus and the Future of Public Health
|
Jul 28, 2015 |
|
A Tool to Strengthen the Voice of Science in Online Journalism
|
Jul 23, 2015 |
|
Father of Child with Rare Disease Says Science Equals Medicine
|
Jul 21, 2015 |
|
Bina CEO Details Secret to Success in NGS Informatics
|
Jul 17, 2015 |
|
Cancer Researcher Tim Triche on the Staying Power of Microarrays
|
Jul 14, 2015 |
|
Want Answers? Look to the Non-Coding Region of the Genome, Says Cancer Researcher, Tim Triche
|
Jul 09, 2015 |
|
Ivan Oransky on Today's Retraction Boom
|
Jul 07, 2015 |
|
Genomics-Palooza, Diagnostics Fraud, and Biblical Prophets on the Future of Biotech
|
Jun 26, 2015 |
|
Ethical Issues around Editing Human Germline for the Future. Today It's about Plants and Animals, Says NYU's Art Caplan
|
Jun 24, 2015 |
|
We Got Research, PCSK9 Inhibitors, and Clinical Trials for Religion
|
Jun 19, 2015 |
|
The Multi-Platform Approach to Clinical Sequencing with Bobby Sebra, Icahn School
|
Jun 15, 2015 |
|
So That Happened, The Mad Genius, and Selling SynBio
|
Jun 12, 2015 |
|
Summer Genomics Festival, the Other Sports Genes, and Brain Surgery for Fruit Flies
|
Jun 05, 2015 |
|
The Sports Genes with Jeremy Koenig, Athletigen
|
Jun 04, 2015 |
|
Woodstock for Genomics? Richard Lumb and Carl Smith on this Month’s Festival
|
Jun 02, 2015 |
|
Geneticists Anonymous, the Sad State of Science Journalism, and New Kids on the Helix
|
May 29, 2015 |
|
The 9 Billion People Problem: Rod Wing on Plant Genomics
|
May 27, 2015 |
|
Should We Hold Back the Reins on Biotechnology? with Chris Gunter
|
May 22, 2015 |
|
Are We Ready to Trust Liquid Biopsies? with Milena Cankovic, Henry Ford Hospital
|
May 19, 2015 |
|
Gene and Tonic: Boxing for Cancer, Dubious Correlations, and When Should a Researcher Retire
|
May 15, 2015 |
|
New Patient Focused Genome Magazine Signing up Many Doctors Too
|
May 12, 2015 |
|
Gene and Tonic: The Decline of Pseudoscience, An Atheist for President, and What to Do with a Sexist Reviewer
|
May 08, 2015 |
|
Gene and Tonic: Sexism in Science, How to Spend an NIH Budget Increase, How Not to Spend It
|
May 01, 2015 |
|
Participation in Genomics Research a 21st Century Public Good, Says Paul Billings of Omicia
|
Apr 15, 2015 |
|
Gene and Tonic: Competition for 23andMe, Four Tips for Attending AACR 2015, and "Swab Stories"
|
Apr 10, 2015 |
|
Improving the Backbone of Clinical Genomics : Valerie Schneider, NCBI
|
Apr 07, 2015 |
|
Gene and Tonic: The ACA Turns Five, Ten Reasons to Have Your Genome Sequenced, and Humbled by the Ancients
|
Apr 03, 2015 |
|
Behind the Sequencing Bench with Dale Yuzuki
|
Mar 31, 2015 |
|
Gene and Tonic: The Tenth Commandment of Science, Icelandic Treasure, and TechBio Babies
|
Mar 27, 2015 |
|
It’s Pretty Bad: Andy Brooks of RUCDR on Sample Quality
|
Mar 19, 2015 |
|
Knowing More about What We Don’t Know: John McPherson on Cancer Genomics
|
Mar 17, 2015 |
|
Gene and Tonic: The iWatch and Research Kit, 23andMe Goes for the Big Time, No Spaceship
|
Mar 13, 2015 |
|
In Partnership with IBM’s Watson, Pathway Genomics Reinvents Itself
|
Mar 12, 2015 |
|
Affymetrix CEO, Frank Witney, on Arrays in the Age of Sequencing
|
Mar 10, 2015 |
|
Gene & Tonic: Disruption in Sequencing, Scientist Politicians, Some Cool Synbio
|
Mar 06, 2015 |
|
Changing the World with Color Changing Flowers
|
Mar 05, 2015 |
|
Cancer Researcher at Mayo Says Illumina Platform Maxing Out, Looks to BGI/Complete
|
Mar 03, 2015 |
|
Returning to Old Biotech Model, OncoMed Boasts of Seven Drugs in Clinical Trials by Mid 2015
|
Feb 24, 2015 |
|
Cutting through the Hype in Healthcare Innovation with David Shaywitz and Lisa Suennen
|
Feb 20, 2015 |
|
A Call to Consumers to Lead the Shift in Healthcare: Sharon Terry, Genetic Alliance
|
Feb 17, 2015 |
|
In Autoimmune Disease, Finding Clarity Beyond the Genome: Stefan Muellner, Protagen
|
Feb 13, 2015 |
|
Myriad Settlements Mark End of an Era: Antoinette Konski on Gene Patents
|
Feb 10, 2015 |
|
David Schwartz on the Future of Sequencing
|
Feb 06, 2015 |
|
Not a Stenographer to Power: Luke Timmerman and the New 'Timmerman Report'
|
Feb 03, 2015 |
|
FDA Will Take Time to Digest Comments on LDT Guidance, Says Liz Mansfield
|
Jan 27, 2015 |
|
Future of Personalized Medicine at Stake, says Amy Miller of PMC about LDT Regulation
|
Jan 23, 2015 |
|
'A Good Year' with John LaMattina
|
Jan 19, 2015 |
|
An Exciting Time for Mass Spec: Paul Beresford, Biodesix
|
Jan 15, 2015 |
|
Current Version of LDT Draft Guidance Means Much Fewer and Lower Quality Tests for Patients, Says Elaine Lyon of ARUP
|
Jan 13, 2015 |
|
The Sad State of Biospecimen Science with David Rimm, Yale
|
Jan 08, 2015 |
|
Cancer 2014: The Year in Review with Anna Barker
|
Dec 30, 2014 |
|
Faces of Leadership in Diagnostics: Surbhi Sarna
|
Dec 18, 2014 |
|
Historic Consensus Reached on Biospecimen Standards: Carolyn Compton, NBDA
|
Dec 16, 2014 |
|
Setting Better Expectations for Genomic Medicine: Geoff Ginsburg, Duke University
|
Dec 09, 2014 |
|
Test Driving Genomic Medicine: Thomas Quertermous, Stanford
|
Dec 03, 2014 |
|
The Silicon Valley Fantasy Trip: Sci-fi Author Kim Stanley Robinson Talks Life Science
|
Nov 25, 2014 |
|
Faces of Leadership in Diagnostics: Mara Aspinall
|
Nov 20, 2014 |
|
The Daunting Task of Managing Biospecimens at the World's Largest CRO: Diane Farhi, Quintiles
|
Nov 18, 2014 |
|
Janet Woodcock, FDA, on Biomarker Development and the Future of Clinical Trials
|
Nov 13, 2014 |
|
Biosampling Basics with Scott Jewell, Van Andel Institute
|
Nov 11, 2014 |
|
Faces of Leadership in Diagnostics: Bonnie Anderson, Veracyte
|
Nov 03, 2014 |
|
Biotech’s Gentleman Lawyer: Alan Mendelson
|
Oct 30, 2014 |
|
The Open Secret about the HER2 Assay with Jim Vaught
|
Oct 28, 2014 |
|
What a Physicist Can Tell Us about Cancer
|
Oct 23, 2014 |
|
'Moving Target Science:' Jonathan Brody on Pancreatic Cancer
|
Oct 21, 2014 |
|
The Progress of Clinical Genomics in Sweden with Ulf Gyllensten
|
Oct 16, 2014 |
|
Proteins Are Where It's At: Chip Petricoin, George Mason University
|
Oct 15, 2014 |
|
After a Decade on the Sidelines, Gene Myers Back into Sequencing, Excited about Long Reads
|
Oct 09, 2014 |
|
The Story of Aubrey de Grey and How the Study of Aging Became Mainstream
|
Oct 07, 2014 |
|
#ScienceHack with Connor Dickie, Synbiota
|
Oct 03, 2014 |
|
What Translational Gap? Michael Pishvaian on Advances in Tumor Profiling
|
Oct 01, 2014 |
|
A Dangerous Book? Science Historian Nathaniel Comfort Discusses “A Troublesome Inheritance”
|
Sep 25, 2014 |
|
Eric Schadt on Long Read Sequencing and Clinical Genomics
|
Sep 23, 2014 |
|
George Church at 60
|
Sep 18, 2014 |
|
Major Sequencing Projects Should Be Done with Long Reads, Says Dan Geraghty
|
Sep 16, 2014 |
|
Test Driving Illumina's X Ten with Shawn Baker, AllSeq
|
Sep 12, 2014 |
|
Short Read Sequencing Not Up to the Task of Characterizing Transcriptome Says Mike Snyder of Stanford
|
Sep 10, 2014 |
|
U.K. Life Science Update with Eliot Forster, MedCity
|
Sep 08, 2014 |
|
Paperwork, Not Algorithms the Biggest Challenge for Large Bioinformatics Projects, Says David Haussler, UCSC
|
Aug 28, 2014 |
|
Big Pharma Does Some Farming: Pearl Huang, GSK
|
Aug 19, 2014 |